|71.36||+0.3950||+0.56%||Vol 129.85K||1Y Perf 8.78%|
|Mar 22nd, 2023 14:52 DELAYED|
|- -%||- -|
|Target Price||90.54||Analyst Rating||Moderate Buy 2.08|
|Potential %||27.49||Finscreener Ranking||★ 41.05|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★+ 42.63|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★ 52.57|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Price Range Ratio 52W %||30.60||Earnings Rating||Sell|
|Market Cap||6.52B||Earnings Date||2nd May 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Valuation||Value||Industry||S&P 500||US Markets|
|Financial Strength||Value||Industry||S&P 500||US Markets|
|Profitability||Value||Industry||S&P 500||US Markets|
|Revenue||Value||Industry||S&P 500||US Markets|
|Dividends||Value||Industry||S&P 500||US Markets|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||2nd May 2023|
|Estimated EPS Next Report||0.71|
|EPS Growth Next 5 Years %||13.00|
|Avg. Weekly Volume||654.77K|
|Avg. Monthly Volume||812.07K|
|Avg. Quarterly Volume||573.28K|
Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 70.96 per share at the end of the most recent trading day (a 0.72% change compared to the prior day closing price) with a volume of 510.12K shares and market capitalization of 6.52B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.
The one-year performance of Acadia Healthcare Company Inc. stock is 8.78%, while year-to-date (YTD) performance is -13.8%. ACHC stock has a five-year performance of 75.04%. Its 52-week range is between 63.2 and 89.85, which gives ACHC stock a 52-week price range ratio of 30.60%
Acadia Healthcare Company Inc. currently has a PE ratio of 26.80, a price-to-book (PB) ratio of 2.75, a price-to-sale (PS) ratio of 3.83, a price to cashflow ratio of 20.80, a PEG ratio of 2.32, a ROA of 6.39%, a ROC of 8.04% and a ROE of 11.75%. The company’s profit margin is 11.21%, its EBITDA margin is 22.30%, and its revenue ttm is $1.94 Billion , which makes it $21.27 revenue per share.
Of the last four earnings reports from Acadia Healthcare Company Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.71 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 02nd May 2023.
The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2.08), with a target price of $90.54, which is +27.49% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Acadia Healthcare Company Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.02, ATR14 : 2.05, CCI20 : -40.12, Chaikin Money Flow : -0.09, MACD : -2.80, Money Flow Index : 47.97, ROC : -4.66, RSI : 39.31, STOCH (14,3) : 50.09, STOCH RSI : 1.00, UO : 59.27, Williams %R : -49.91), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were: Christopher L. Howard (Option Excercise at a value of $311 453), Christopher L. Howard (Sold 20 657 shares of value $1 685 706 ), David Duckworth (Sold 26 921 shares of value $2 170 677 ), John S. Hollinsworth (Sold 10 780 shares of value $869 730 ), William F. Grieco (Sold 5 000 shares of value $412 700 )
|Analyst Ratings||Current||1 M ago||3 M ago|
|Summary Rating||Moderate Buy||Moderate Buy||Moderate Buy|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
CEO: Debra K. Osteen
Telephone: +1 615 861-6000
Address: 6100 Tower Circle, Franklin 37067, TN, US
Number of employees: 42 800
Sat, 04 Mar 2023 01:55 GMT Acadia Healthcare (ACHC) Gets a Buy from RBC Capital- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.